[go: up one dir, main page]

WO2006130689A3 - Detecting prostate cancer - Google Patents

Detecting prostate cancer Download PDF

Info

Publication number
WO2006130689A3
WO2006130689A3 PCT/US2006/021118 US2006021118W WO2006130689A3 WO 2006130689 A3 WO2006130689 A3 WO 2006130689A3 US 2006021118 W US2006021118 W US 2006021118W WO 2006130689 A3 WO2006130689 A3 WO 2006130689A3
Authority
WO
WIPO (PCT)
Prior art keywords
prostate cancer
detecting prostate
materials
methods
dipeptidylpeptidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/021118
Other languages
French (fr)
Other versions
WO2006130689A2 (en
Inventor
Michael J Wilson
Neil F Wasserman
Akhouri Sinha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota Twin Cities
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Publication of WO2006130689A2 publication Critical patent/WO2006130689A2/en
Anticipated expiration legal-status Critical
Publication of WO2006130689A3 publication Critical patent/WO2006130689A3/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

This document provides methods and materials related to detecting prostate cancer. For example, methods and materials for assessing the likelihood of prostate cancer in a mammal by determining the level of a dipeptidylpeptidase IV polypeptide are provided. Methods and materials for assessing prostate cancer progression and prostate cancer regression in a mammal by determining the level of a dipeptidylpeptidase IV polypeptide also are provided.
PCT/US2006/021118 2005-06-02 2006-06-01 Detecting prostate cancer Ceased WO2006130689A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68667305P 2005-06-02 2005-06-02
US60/686,673 2005-06-02

Publications (2)

Publication Number Publication Date
WO2006130689A2 WO2006130689A2 (en) 2006-12-07
WO2006130689A3 true WO2006130689A3 (en) 2007-12-06

Family

ID=37482264

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/021118 Ceased WO2006130689A2 (en) 2005-06-02 2006-06-01 Detecting prostate cancer

Country Status (1)

Country Link
WO (1) WO2006130689A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008151238A1 (en) * 2007-06-04 2008-12-11 The Johns Hopkins University Biomarkers for prostate cancer
SE535084C2 (en) * 2010-04-16 2012-04-10 Prostasom Handelsbolag Procedure for cancer diagnosis

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ADBEL-KHALEK ET AL.: "Is transition zone biopsy vuluable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?", SCAND. J. UROL. NEPHROL., vol. 39, no. 1, 2005, pages 49 - 55, XP008091907 *
BOGENRIEDER ET AL.: "Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue", PROSTATE, vol. 33, no. 4, 1 December 1997 (1997-12-01), pages 225 - 232, XP009058196 *
DURKAN ET AL.: "Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol", BJU INT., vol. 89, no. 1, January 2002 (2002-01-01), pages 33 - 39, XP008091292 *
JALAL ET AL.: "Polarized distribution of neutral endopeptidase 24.11 at the cell surface of cultured human intestinal epithelial Caco-2 cells", BIOCHEM. J., vol. 288, no. 3, 15 December 1992 (1992-12-15), pages 945 - 951, XP008091212 *
WILSON ET AL.: "Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands", J. ANDROL., vol. 21, no. 2, March 2000 (2000-03-01) - April 2000 (2000-04-01), pages 220 - 226, XP008091383 *
WILSON ET AL.: "Dipeptidylpeptidase IV activities in prostatic secretions", ADV. EXP. MED. BIOL., vol. 524, 2003, pages 257 - 260, XP008091178 *
WILSON ET AL.: "Elevation of dipeptidylpeptidase iv activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker", J. UROL., vol. 174, no. 3, September 2005 (2005-09-01), pages 1124 - 1128, XP005382410 *

Also Published As

Publication number Publication date
WO2006130689A2 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
WO2008061104A3 (en) Methods and kits for detecting prostate cancer biomarkers
WO2007082154A3 (en) B7-h1 and b7-h4 in cancer
EP1922326A4 (en) Biomarkers useful for diagnosing prostate cancer, and methods thereof
WO2007082144A3 (en) B7-h1 and survivin in cancer
WO2006089125A3 (en) Methods of detecting ovarian cancer
WO2009036427A3 (en) Prostate cancer biomarkers
WO2007076439A3 (en) Methods and marker combinations for screening for predisposition to lung cancer
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
DK2044120T3 (en) ANTIBODIES THAT RECOGNIZE A CARBOHYDRATE-CONTAINING EPITOP ON CD-43 AND CEA EXPRESSED ON CANCER CELLS, AND METHODS FOR USING IT
WO2006105338A3 (en) Fc VARIANTS WITH OPTIMIZED PROPERTIES
WO2007041635A3 (en) Fc variants with optimized fc receptor binding properties
WO2008048970A3 (en) Synthetic antibodies
FI20055038A0 (en) Security in the Mobile Email Service
WO2011062803A3 (en) Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
WO2007008759A3 (en) Methods for detecting and confirming minimal disease in a cancer patient
WO2007124361A3 (en) Soluble b7-h1
WO2010009368A3 (en) Compositions for the detection and treatment of colorectal cancer
DK2024747T3 (en) Use of protein SATB2 as a prognotic marker for colerectal cancer
GB2440870B (en) Automated payment system with additional capability
DE602005025805D1 (en) STABILIZED POLYMER THIOL REAGENTS
WO2008079185A3 (en) Pesticide biomarker
WO2010009171A3 (en) Src activation for determining cancer prognosis and as a target for cancer therapy
WO2008102340A3 (en) Kits and methods for determining colon cleanliness
NL1032881A1 (en) Optical sample characterization system.
WO2008096570A1 (en) Microchip and microchip inspection system

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2008514807

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 06760593

Country of ref document: EP

Kind code of ref document: A2